{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:19:25Z","timestamp":1789906765817,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI 095227-02"],"award-info":[{"award-number":["AI 095227-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI 111820"],"award-info":[{"award-number":["AI 111820"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI124456"],"award-info":[{"award-number":["AI124456"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL 090664-04"],"award-info":[{"award-number":["HL 090664-04"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jaci.2017.11.043","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T03:10:03Z","timestamp":1515553803000},"page":"1515-1528.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in\u00a0vivo"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4379-9118","authenticated-orcid":false,"given":"Shinji","family":"Toki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasia","family":"Goleniewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Reiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa H.","family":"Bloodworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Stier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weisong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn C.","family":"Newcomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine B.","family":"Ware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg D.","family":"Stanwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelio","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli L.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Niswender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"R. Stokes","family":"Peebles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2017.11.043_bib1","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jaci.2012.04.041","article-title":"Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseases","volume":"130","author":"Li","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2017.11.043_bib2","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1111\/all.12990","article-title":"Combining genomewide association study and lung eQTL analysis provides evidence for novel genes associated with asthma","volume":"71","author":"Nieuwenhuis","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2017.11.043_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-065X.2011.01029.x","article-title":"The genetics of asthma and allergic disease: a 21st century perspective","volume":"242","author":"Ober","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2017.11.043_bib4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jaci.2013.12.1080","article-title":"Association of IL33\u2013IL-1 receptor\u2013like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood","volume":"134","author":"Savenije","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2017.11.043_bib5","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.jaci.2015.10.003","article-title":"Airway epithelial dual oxidase 1 mediates allergen-induced IL-33 secretion and activation of type 2 immune responses","volume":"137","author":"Hristova","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2017.11.043_bib6","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2011.12.020","article-title":"Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation","volume":"36","author":"Halim Timotheus","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2017.11.043_bib7","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.4049\/jimmunol.1102832","article-title":"IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs","volume":"188","author":"Bartemes","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2017.11.043_bib8","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.4049\/jimmunol.181.7.4780","article-title":"IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4","volume":"181","author":"Kurowska-Stolarska","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2017.11.043_bib9","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.anai.2016.04.022","article-title":"The immunobiology of asthma: asthma phenotypes and their implications for personalized treatment","volume":"117","author":"Borish","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"suppl","key":"10.1016\/j.jaci.2017.11.043_bib10","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.2337\/db06-S020","article-title":"Glucagon-like peptide 1 secretion by the L-cell: the view from within","volume":"55","author":"Lim","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.jaci.2017.11.043_bib11","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2337\/diacare.23.6.807","article-title":"Evaluation of beta-cell secretory capacity using glucagon-like peptide 1","volume":"23","author":"Vilsboll","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaci.2017.11.043_bib12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cmet.2010.04.007","article-title":"GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis","volume":"11","author":"De Marinis","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.jaci.2017.11.043_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fnut.2015.00023","article-title":"The L-cell in nutritional sensing and the regulation of appetite","volume":"2","author":"Spreckley","year":"2015","journal-title":"Front Nutr"},{"key":"10.1016\/j.jaci.2017.11.043_bib14","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMp1314078","article-title":"Pancreatic safety of incretin-based drugs-FDA and EMA assessment","volume":"370","author":"Egan","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2017.11.043_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s13300-014-0087-6","article-title":"Glucagon-like peptide-1 receptor agonist treatment patterns among type 2 diabetes patients in six European countries","volume":"5","author":"Divino","year":"2014","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jaci.2017.11.043_bib16","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00125-013-3145-0","article-title":"Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus","volume":"57","author":"Hogan","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaci.2017.11.043_bib17","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1007\/s00125-012-2592-3","article-title":"Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes","volume":"55","author":"Lee","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaci.2017.11.043_bib18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/JIR.S84993","article-title":"Effects of exendin-4, a glucagon like peptide-1 receptor agonist, on neutrophil count and inflammatory cytokines in a rat model of endotoxemia","volume":"8","author":"Yanay","year":"2015","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.jaci.2017.11.043_bib19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/bph.12490","article-title":"Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration","volume":"171","author":"Wang","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jaci.2017.11.043_bib20","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.intimp.2014.07.010","article-title":"Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-kappaB in mice","volume":"22","author":"Gou","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaci.2017.11.043_bib21","doi-asserted-by":"crossref","first-page":"20195","DOI":"10.3390\/ijms160920195","article-title":"Glucagon like peptide-1 (GLP-1) modulates OVA-induced airway inflammation and mucus secretion involving a protein kinase A\u00a0(PKA)-dependent nuclear factor-kappaB (NF-kappaB) signaling pathway in mice","volume":"16","author":"Zhu","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2017.11.043_bib22","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.4049\/jimmunol.1003020","article-title":"The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses","volume":"186","author":"Kouzaki","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2017.11.043_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1056\/NEJM199102073240602","article-title":"Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma","volume":"324","author":"O'Hollaren","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2017.11.043_bib24","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/eji.201242863","article-title":"IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation","volume":"43","author":"Hardman","year":"2013","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2017.11.043_bib25","doi-asserted-by":"crossref","first-page":"e809","DOI":"10.1038\/tp.2016.86","article-title":"Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels","volume":"6","author":"Reddy","year":"2016","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.jaci.2017.11.043_bib26","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jaci.2014.02.002","article-title":"Alternaria-derived serine protease activity drives IL-33\u2013mediated asthma exacerbations","volume":"134","author":"Snelgrove","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2017.11.043_bib27","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.1073\/pnas.1605957113","article-title":"Leukotriene E4 elicits respiratory epithelial cell mucin release through the G-protein-coupled receptor, GPR99","volume":"113","author":"Bankova","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2017.11.043_bib28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/thoraxjnl-2015-207728","article-title":"The histone deacetylase inhibitor trichostatin A\u00a0suppresses murine innate allergic inflammation by blocking group 2 innate lymphoid cell (ILC2) activation","volume":"71","author":"Toki","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2017.11.043_bib29","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1172\/JCI5909","article-title":"Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production","volume":"103","author":"Zhu","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2017.11.043_bib30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13223-015-0090-0","article-title":"Risk factors associated with asthma, atopic dermatitis and rhinoconjunctivitis in a rural Senegalese cohort","volume":"11","author":"Herrant","year":"2015","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaci.2017.11.043_bib31","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1210\/en.2013-1934","article-title":"GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody","volume":"155","author":"Pyke","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaci.2017.11.043_bib32","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2337\/db09-1694","article-title":"Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4","volume":"59","author":"Arakawa","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.jaci.2017.11.043_bib33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejphar.2012.12.012","article-title":"The type 2 diabetes drug liraglutide reduces chronic inflammation induced by irradiation in the mouse brain","volume":"700","author":"Parthsarathy","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaci.2017.11.043_bib34","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.neures.2006.04.008","article-title":"Glucagon-like peptide-1 inhibits LPS-induced IL-1\u03b2 production in cultured rat astrocytes","volume":"55","author":"Iwai","year":"2006","journal-title":"Neurosci Res"},{"key":"10.1016\/j.jaci.2017.11.043_bib35","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1210\/en.2013-1666","article-title":"Glucagon-like peptide-1 (GLP-1) reduces mortality and improves lung function in a model of experimental obstructive lung disease in female mice","volume":"154","author":"Viby","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaci.2017.11.043_bib36","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jaci.2017.11.043_bib37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pupt.2012.05.007","article-title":"cAMP regulation of airway smooth muscle function","volume":"26","author":"Billington","year":"2013","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.jaci.2017.11.043_bib38","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1189\/jlb.0606375","article-title":"Prostaglandin I2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cells","volume":"81","author":"Zhou","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2017.11.043_bib39","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4049\/jimmunol.178.2.702","article-title":"Prostaglandin I2 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells","volume":"178","author":"Zhou","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2017.11.043_bib40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1164\/rccm.201410-1793OC","article-title":"Prostaglandin I2 signaling and inhibition of group 2 innate lymphoid cell responses","volume":"193","author":"Zhou","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2017.11.043_bib41","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.1206587110","article-title":"IL-33 drives biphasic IL-13 production for noncanonical type 2 immunity against hookworms","volume":"110","author":"Hung","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2017.11.043_bib42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2796.2010.02316.x","article-title":"Interleukin-33: a novel mediator with a role in distinct disease pathologies","volume":"269","author":"Kurowska-Stolarska","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/j.jaci.2017.11.043_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coi.2014.09.004","article-title":"IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy","volume":"31","author":"Cayrol","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2017.11.043_bib44","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.atherosclerosis.2011.12.039","article-title":"The\u00a0glucagon-like peptide 1 analog liraglutide reduces TNF-alpha-induced oxidative stress and inflammation in endothelial cells","volume":"221","author":"Shiraki","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jaci.2017.11.043_bib45","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/mi.2015.59","article-title":"Group 2 innate lymphoid cells utilize the IRF4-IL-9 module to coordinate epithelial cell maintenance of lung homeostasis","volume":"1","author":"Mohapatra","year":"2016","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2017.11.043_bib46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000327259","article-title":"Expression and effects of IL-33 and ST2 in allergic bronchial asthma: IL-33 induces eotaxin production in lung fibroblasts","volume":"155","author":"Kurokawa","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2017.11.043_bib47","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/eji.201041033","article-title":"IL-33-activated dendritic cells are critical for allergic airway inflammation","volume":"41","author":"Besnard","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2017.11.043_bib48","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1007\/s00125-011-2232-3","article-title":"Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis","volume":"54","author":"Hogan","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaci.2017.11.043_bibE1","series-title":"Suppression and regulation of immune responses, methods and protocols","first-page":"207","article-title":"Anti-inflammatory and immunosuppressive functions of mast cells","volume":"Volume 677","author":"Kalesnikoff","year":"2011"},{"key":"10.1016\/j.jaci.2017.11.043_bibE2","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.4049\/jimmunol.165.10.5509","article-title":"Eosinophil major basic protein-1 does not contribute to allergen-induced airway pathologies in mouse models of asthma","volume":"165","author":"Denzler","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2017.11.043_bibE3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/(SICI)1096-9071(199902)57:2<186::AID-JMV17>3.0.CO;2-Q","article-title":"Respiratory syncytial virus infection prolongs methacholine-induced airway hyperresponsiveness in ovalbumin-sensitized mice","volume":"57","author":"Peebles","year":"1999","journal-title":"J Med Virol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918300277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918300277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:12:53Z","timestamp":1758791573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674918300277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0091674918300277"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2017.11.043","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in\u00a0vivo","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2017.11.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}